phenylbenzoquinone has been researched along with Nociceptive Pain in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Alves-Filho, JC; Casagrande, R; Cunha, FQ; Cunha, TM; Ferreira, SH; Hohmann, MS; Liew, FY; Magro, DA; Mizokami, SS; Verri, WA | 1 |
Casagrande, R; Cunha, FQ; Cunha, TM; Ferreira, SH; Mizokami, SS; Pavao-de-Souza, GF; Sanson, JS; Tedeschi, GC; Verri, WA; Zarpelon, AC | 1 |
2 other study(ies) available for phenylbenzoquinone and Nociceptive Pain
Article | Year |
---|---|
An interleukin-33/ST2 signaling deficiency reduces overt pain-like behaviors in mice.
Topics: Acetic Acid; Animals; Benzoquinones; Homozygote; Hot Temperature; Hyperalgesia; Interleukin-1 Receptor-Like 1 Protein; Interleukin-33; Interleukins; Mice; Mice, Inbred BALB C; Motor Activity; Nociception; Nociceptive Pain; Ovalbumin; Pain Measurement; Receptors, Interleukin; Rotarod Performance Test; Signal Transduction | 2013 |
Acetic acid- and phenyl-p-benzoquinone-induced overt pain-like behavior depends on spinal activation of MAP kinases, PI(3)K and microglia in mice.
Topics: Acetic Acid; Androstadienes; Animals; Anthracenes; Benzoquinones; Disease Models, Animal; Flavonoids; Imidazoles; Injections, Spinal; Male; MAP Kinase Signaling System; Mice; Microglia; Nociception; Nociceptive Pain; Pain; Pain Measurement; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Pyridines; Spinal Cord; Wortmannin | 2012 |